Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number 0-26301 United Therapeutics Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 52-19847 ...

United Therapeutics Corporation (NASDAQ:UTHR) Q4 2020 Earnings Conference Call February 24, 2021 9:00 AM ET Company Participants Dewey Steadman - Head, IR Martine Rothblatt - Chairman and CEO Michael Benkowitz - President and COO Leigh Peterson - VP, Product Development James Edgemond - CFO and Treasurer Conference Call Participants Joseph Thome - Cowen and Company Liana Moussatos - Wedbush Eun Yang - Jefferies Jessica Fye - JPMorgan Martin Auster - Credit Suisse Hartaj Singh - Oppenheimer Terence Flynn - G ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number 0-26301 United Therapeutics Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 52-1984749 (S ...

United Therapeutics Corporation (NASDAQ:UTHR) Q3 2020 Earnings Conference Call October 28, 2020 9:00 AM ET Corporate Participants Dewey Steadman - Head, Investor Relations Martine Rothblatt - Chairman & Chief Executive Officer Michael Benkowitz - President & Chief Operating Officer Leigh Peterson - Vice President, Product Development James Edgemond - Chief Financial Officer & Treasurer Conference Call Participants Hartaj Singh - Oppenheimer Eun Yang - Jefferies Martin Auster - Credit Suisse Joseph Thome - C ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number 0-26301 United Therapeutics Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 52-1 ...

UNITED THERAPEUTICS CORPORATION August 2020 SAFE HARBOR STATEMENT | --- | --- | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

United Therapeutics Corporation (NASDAQ:UTHR) Q2 2020 Earnings Conference Call July 29, 2020 9:00 AM ET Corporate Participants Dewey Steadman - Head, Investor Relations Martine Rothblatt - Chairman and Chief Operating Officer Mike Benkowitz - President and Chief Operating Officer Leigh Peterson - Vice President, Product Development Conference Call participants Hartaj Singh - Oppenheimer Eun Yang - Jefferies Martin Auster - Credit Suisse Liana Moussatos - Wedbush Securities Christopher Zopf - Cowen and Compa ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the transition period from to Commission file number 0-26301 United Therapeutics Corporation (Exact Name of Registrant as Specified in Its Charter) | Delaware | | --- ...

UNITED THERAPEUTICS CORPORATION May 2020 SAFE HARBOR STATEMENT | --- | --- | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

United Therapeutics Corporation (NASDAQ:UTHR) Q1 2020 Earnings Conference Call April 29, 2020 9:00 AM ET Company Participants Dewey Steadman - Head, IR Martine Rothblatt - Chairman & CEO Michael Benkowitz - President & COO Leigh Peterson - VP, Product Development James Edgemond - CFO & Treasurer Conference Call Participants Chris Shibutani - Cowen Eun Yang - Jefferies Hartaj Singh - Oppenheimer Jessica Fye - JPMorgan Liana Moussatos - Wedbush Securities Martin Auster - Credit Suisse Operator Good morning, a ...